FDA: Man gets terminally ill after taking weight-loss drug

No time to read?
Get a summary

The Food and Drug Administration (FDA) has warned that using apetamine to gain weight can lead to coma or death. This was reported in a press release posted on the agency’s website.

Apetamin is a syrup containing the powerful antihistamine cyproheptadine. The agency received medical reports from men who took apetamine to improve their fitness. They suffered from nervous system ailments, heart ailments, and liver damage.

In a published report, a person who took apetamine every day for six weeks developed autoimmune hepatitis. This chronic disease is treated with hormonal drugs that suppress the immune system. If left untreated, hepatitis can lead to liver failure.

Other dangerous side effects of apetamine include dizziness, low blood pressure, disorientation and confusion, hallucinations, seizures, slowed breathing and heart rate. According to the FDA, the drug can lead to coma or death.

This substance also reduces mental alertness, which may affect a person’s ability to drive or use machines.

Apetamin is especially dangerous when taken with alcohol and other central nervous system depressants (hypnotics, sedatives, tranquilizers).

No time to read?
Get a summary
Previous Article

Scientists identify factors that cause long-term weight loss

Next Article

Defender of “Boston” Orlov announced that he wants to return to “Washington”